Retinal disorders have received considerable attention from researchers and other experts over the course of the past couple of decades. However, prior to that timeframe, retinal disorders were largely sidelined as the primary cause of blindness in the blindness programs in most of developing regions. A number of factors, including high costs involved in the treatment of retinal disorders, steep costs, and unreliability of the equipment utilized were some of the common factors that led to a sluggish growth of the retinal disorders treatment market in several developing regions. Over the past few years, advancements in technology coupled with promising findings from research and development activities have contributed to the overall development of the global retinal disorders treatment market– a trend that is projected to continue over the duration of the forecast period.
Increasing prevalence of retinal disorders in both, developing as well as developed regions of the world is expected to drive innovations, accelerate new treatments, and play an important role in increasing investments toward the overall development of the retinal disorders treatment market. Furthermore, the growing prevalence of diabetes around the world is another factor that is expected to augment the number of patients suffering from retinal disorders– a factor that is projected to boost the growth of the global retinal disorders treatment market during the assessment period. The increasing support offered by governments, particularly in developing regions has led to a considerable growth of the overall awareness pertaining to various retinal disorders due to which, the demand for retinal disorders treatment has witnessed a notable spike. This factor is anticipated to boost the prospects of the global retinal disorders treatment market during the stipulated timeframe of the study.
At the back of these factors, the global retinal disorders treatment market is on the course to surpass the US$ 19 Bn mark by the end of 2030.
Technological advancements are set to play a key role in the overall growth of the global retinal disorders treatment market in the upcoming years. Groundbreaking breakthroughs and advancements in bionics, genetics, and stem-cell therapy are expected to transform the future of retinal disorders treatment in the upcoming decade. In developed regions wherein the preventable causes of blindness are detected early, owing to routine checkups and robust healthcare ecosystem, retinal degeneration has emerged as one of the top causes of blindness or visual impairment. Advancements across several new frontiers are expected to pave the way for new retinal disorders treatments for all the major forms of retinal disorders. Advancements in gene therapy, functional prostheses, and growing interest in bionic eyes are projected to play a vital role in boosting the growth of the global retinal disorders treatment market during the forecast period. While gene therapy is likely to emerge as a promising retinal disorder treatment, cell regeneration or stem-cell therapy has offered considerable promise in the treatment of blindness, especially in the later stages of the disease. Advancements in technology coupled with research and development activities are expected to play a key role in boosting the growth of the global retinal disorders treatment market during the assessment period.
The onset of the COVID-19 pandemic is expected to have a moderate impact on the overall growth of the global retinal disorders treatment market in 2020. While the major focus is projected to remain toward the discovery of new vaccine, research and development activities in other branches of the medical sectors are likely to continue as per the initial timeline. Research activities are also anticipated to evaluate the presence of retinal alterations among patients suffering from the novel COVID-19 infection. Due to the constant fear of contracting the virus, doctors and specialists are expected to rely on telehealth services. Although the trends suggest that patients are willing to delay retinal disorders treatment due to the ongoing pandemic, the market is likely to show signs of recovery toward the last quarter of 2020.
Analysts’ Viewpoint
The global retinal disorders treatment market is anticipated to expand at a healthy CAGR of ~7% during the forecast period. The market growth is primarily driven by increasing prevalence of retinal disorders worldwide, advancements in technology, including gene therapy and stem-cell therapy, research and development activities, and rising awareness regarding recent research findings and progress made in the retinal disorders treatment market. Market players should focus on research and development activities and continue to explore the potential of different technologies that could be utilized for retinal disorders treatment.
Retinal Disorders Treatment Market – Segmentation
TMR’s study on the global retinal disorders treatment market includes information divided into five segments: indication, dosage form, therapeutic class, distribution channel, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global retinal disorders treatment market have been discussed in detail.
|
Indication |
|
|
Therapeutic Class |
|
|
Dosage Form |
|
|
Distribution Channel |
|
|
Region |
|
The global retinal disorders treatment market was worth US$ 9.18 Bn and is projected to reach a value of US$ 19 Bn by the end of 2030
Retinal disorders treatment market is anticipated to grow at a CAGR of 7% during the forecast period
North America accounted for a major share of the global retinal disorders treatment market
Retinal disorders treatment market is driven by increasing prevalence of retinal disorders worldwide, advancements in technology, including gene therapy and stem-cell therapy, research and development activities, and rising awareness regarding recent research findings
Key players in the global retinal disorders treatment market include Allergan plc, Bayer AG, F. Hoffmann-La Roche Ltd., Graybug Vision, Inc., Kubota Pharmaceutical Holdings Co., Ltd., Novartis AG, Pfizer, Inc., Regeneron Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd., and Takeda Pharmaceutical Company Limited
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Retinal Disorders Treatment Market
4. Market Overview
4.1. Introduction & Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Global Retinal Disorders Treatment Market Analysis and Forecast, 2018–2030
5. Market Outlook
5.1. COVID-19 Pandemics Impact on Industry
5.2. Clinical Trial Analysis
5.3. Regulatory Scenario
5.4. Pipeline Analysis
5.5. Key Potential Customers
5.6. Key Vendor and Distributor Analysis
5.7. Key Industry Events
5.8. Reimbursement Scenario
5.9. Retinal Disorders: Epidemiology Forecast
6. Global Retinal Disorders Treatment Market Analysis and Forecast, by Indication
6.1. Introduction & Definition
6.2. Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
6.2.1. Macular Degeneration
6.2.1.1. Dry Macular Degeneration
6.2.1.2. Wet Macular Degeneration
6.2.2. Diabetic Retinopathy
6.2.3. Diabetic Macular Edema
6.2.4. Others
6.3. Global Retinal Disorders Treatment Market Attractiveness Analysis, by Indication
7. Global Retinal Disorders Treatment Market Analysis and Forecast, by Therapeutic Class
7.1. Introduction & Definition
7.2. Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018–2030
7.2.1. Anti-VEGF Agents
7.2.2. Others
7.3. Global Retinal Disorders Treatment Market Attractiveness Analysis, by Therapeutic Class
8. Global Retinal Disorders Treatment Market Analysis and Forecast, by Dosage Form
8.1. Introduction & Definition
8.2. Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
8.2.1. Gels
8.2.2. Eye Solutions
8.2.3. Capsules & Tablets
8.2.4. Eye Drops
8.2.5. Ointments
8.3. Global Retinal Disorders Treatment Market Attractiveness Analysis, by Dosage Form
9. Global Retinal Disorders Treatment Market Analysis and Forecast, by Distribution Channel
9.1. Introduction & Definition
9.2. Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
9.2.1. Hospital Pharmacies
9.2.2. Retail Pharmacies
9.2.3. Online Sales
9.3. Global Retinal Disorders Treatment Market Attractiveness Analysis, by Distribution Channel
10. Global Retinal Disorders Treatment Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Region
10.2.1. U.S.
10.2.2. Europe
10.2.3. China
10.2.4. Russia
10.2.5. Rest of the World (RoW)
10.3. Global Retinal Disorders Treatment Market Attractiveness Analysis, by Region
11. U.S. Retinal Disorders Treatment Market Analysis and Forecast
11.1. Introduction
11.2. U.S. Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
11.2.1. Macular Degeneration
11.2.1.1. Dry Macular Degeneration
11.2.1.2. Wet Macular Degeneration
11.2.2. Diabetic Retinopathy
11.2.3. Diabetic Macular Edema
11.2.4. Others
11.3. U.S. Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018–2030
11.3.1. Anti-VEGF Agents
11.3.2. Others
11.4. U.S. Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
11.4.1. Gels
11.4.2. Eye Solutions
11.4.3. Capsules & Tablets
11.4.4. Eye Drops
11.4.5. Ointments
11.5. U.S. Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
11.5.1. Hospital Pharmacies
11.5.2. Retail Pharmacies
11.5.3. Online Sales
11.6. U.S. Retinal Disorders Treatment Market Attractiveness Analysis
11.6.1. By Indication
11.6.2. By Therapeutic Class
11.6.3. By Dosage Form
11.6.4. By Distribution Channel
12. Europe Retinal Disorders Treatment Market Analysis and Forecast
12.1. Introduction
12.2. Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
12.2.1. Macular Degeneration
12.2.1.1. Dry Macular Degeneration
12.2.1.2. Wet Macular Degeneration
12.2.2. Diabetic Retinopathy
12.2.3. Diabetic Macular Edema
12.2.4. Others
12.3. Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018–2030
12.3.1. Anti-VEGF Agents
12.3.2. Others
12.4. Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
12.4.1. Gels
12.4.2. Eye Solutions
12.4.3. Capsules & Tablets
12.4.4. Eye Drops
12.4.5. Ointments
12.5. Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
12.5.1. Hospital Pharmacies
12.5.2. Retail Pharmacies
12.5.3. Online Sales
12.6. Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Europe Retinal Disorders Treatment Market Attractiveness Analysis
12.7.1. By Indication
12.7.2. By Therapeutic Class
12.7.3. By Dosage Form
12.7.4. By Distribution Channel
12.7.5. By Country/Sub-region
13. China Retinal Disorders Treatment Market Analysis and Forecast
13.1. Introduction
13.2. China Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
13.2.1. Macular Degeneration
13.2.1.1. Dry Macular Degeneration
13.2.1.2. Wet Macular Degeneration
13.2.2. Diabetic Retinopathy
13.2.3. Diabetic Macular Edema
13.2.4. Others
13.3. China Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018–2030
13.3.1. Anti-VEGF Agents
13.3.2. Others
13.4. China Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
13.4.1. Gels
13.4.2. Eye Solutions
13.4.3. Capsules & Tablets
13.4.4. Eye Drops
13.4.5. Ointments
13.5. China Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
13.5.1. Hospital Pharmacies
13.5.2. Retail Pharmacies
13.5.3. Online Sales
13.6. China Retinal Disorders Treatment Market Attractiveness Analysis
13.6.1. By Indication
13.6.2. By Therapeutic Class
13.6.3. By Dosage Form
13.6.4. By Distribution Channel
14. Russia Retinal Disorders Treatment Market Analysis and Forecast
14.1. Introduction
14.2. Russia Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
14.2.1. Macular Degeneration
14.2.1.1. Dry Macular Degeneration
14.2.1.2. Wet Macular Degeneration
14.2.2. Diabetic Retinopathy
14.2.3. Diabetic Macular Edema
14.2.4. Others
14.3. Russia Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018–2030
14.3.1. Anti-VEGF Agents
14.3.2. Others
14.4. Russia Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
14.4.1. Gels
14.4.2. Eye Solutions
14.4.3. Capsules & Tablets
14.4.4. Eye Drops
14.4.5. Ointments
14.5. Russia Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
14.5.1. Hospital Pharmacies
14.5.2. Retail Pharmacies
14.5.3. Online Sales
14.6. Russia Retinal Disorders Treatment Market Attractiveness Analysis
14.6.1. By Indication
14.6.2. By Therapeutic Class
14.6.3. By Dosage Form
14.6.4. By Distribution Channel
15. Rest of the World Retinal Disorders Treatment Market Analysis and Forecast
15.1. Introduction
15.2. Rest of the World Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
15.2.1. Macular Degeneration
15.2.1.1. Dry Macular Degeneration
15.2.1.2. Wet Macular Degeneration
15.2.2. Diabetic Retinopathy
15.2.3. Diabetic Macular Edema
15.2.4. Others
15.3. Rest of the World Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018–2030
15.3.1. Anti-VEGF Agents
15.3.2. Others
15.4. Rest of the World Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
15.4.1. Gels
15.4.2. Eye Solutions
15.4.3. Capsules & Tablets
15.4.4. Eye Drops
15.4.5. Ointments
15.5. Rest of the World Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
15.5.1. Hospital Pharmacies
15.5.2. Retail Pharmacies
15.5.3. Online Sales
15.6. Rest of the World Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
15.6.1. Canada
15.6.2. India
15.6.3. Japan
15.6.4. Australia
15.6.5. Brazil
15.6.6. Rest of Rest of the World
15.7. Rest of the World Retinal Disorders Treatment Market Attractiveness Analysis
15.7.1. By Indication
15.7.2. By Therapeutic Class
15.7.3. By Dosage Form
15.7.4. By Distribution Channel
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Position Analysis, by Company, 2019
16.2. Company Profiles
16.2.1. Allergan plc
16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.1.2. Growth Strategies
16.2.1.3. SWOT Analysis
16.2.2. Bayer AG
16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.2.2. Growth Strategies
16.2.2.3. SWOT Analysis
16.2.3. F. Hoffmann-La Roche Ltd.
16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.3.2. Growth Strategies
16.2.3.3. SWOT Analysis
16.2.4. Graybug Vision, Inc.
16.2.4.1. Company Overview (HQ, Business Segments)
16.2.4.2. Growth Strategies
16.2.4.3. SWOT Analysis
16.2.5. Kubota Pharmaceutical Holdings Co., Ltd.
16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.5.2. Growth Strategies
16.2.5.3. SWOT Analysis
16.2.6. Novartis AG
16.2.6.1. Company Overview (HQ, Business Segments)
16.2.6.2. Growth Strategies
16.2.6.3. SWOT Analysis
16.2.7. Pfizer, Inc.
16.2.7.1. Company Overview (HQ, Business Segments)
16.2.7.2. Growth Strategies
16.2.7.3. SWOT Analysis
16.2.8. Regeneron Pharmaceuticals, Inc.
16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.8.2. Growth Strategies
16.2.8.3. SWOT Analysis
16.2.9. Santen Pharmaceutical Co., Ltd.
16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.9.2. Growth Strategies
16.2.9.3. SWOT Analysis
16.2.10. Takeda Pharmaceutical Company Limited
16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.10.2. Growth Strategies
16.2.10.3. SWOT Analysis
List of Tables
Table 01: Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 02: Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018–2030
Table 03: Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
Table 04: Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 05: Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 06: U.S. Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 07: U.S. Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018–2030
Table 08: U.S. Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
Table 09: U.S. Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 10: Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 11: Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018–2030
Table 12: Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
Table 13: Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 14: Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 15: China Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 16: China Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018–2030
Table 17: China Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
Table 18: China Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 19: Russia Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 20: Russia Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018–2030
Table 21: Russia Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
Table 22: Russia Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 23: Rest of the World (ROW) Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 24: Rest of the World (ROW) Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018–2030
Table 25: Rest of the World (ROW) Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
Table 26: Rest of the World (ROW) Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 27: Rest of the World (ROW) Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
List of Figures
Figure 01: Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, 2018–2030
Figure 02: Global Retinal Disorders Treatment Market Value Share, by Indication, 2019
Figure 03: Global Retinal Disorders Treatment Market Value Share, by Dosage Form, 2019
Figure 04: Global Retinal Disorders Treatment Market Value Share, by Therapeutic Class, 2019
Figure 05: Global Retinal Disorders Treatment Market Value Share, by Distribution Channel, 2019
Figure 06: Global Retinal Disorders Treatment Market Value Share, by Region, 2019
Figure 07: Clinical Trial Analysis, by Phase
Figure 08: Clinical Trial Analysis, by Status
Figure 09: Clinical Trial Analysis, by Completion and Termination Rate
Figure 10: Clinical Trial Analysis, by Region
Figure 11: Global Retinal Disorders Treatment Market Value Share Analysis, by Indication, 2019 and 2030
Figure 12: Global Retinal Disorders Treatment Market Attractiveness Analysis, by Indication, 2020–2030
Figure 13: Global Retinal Disorders Treatment Market Value (US$ Mn), by Macular Degeneration, 2018–2030
Figure 14: Global Retinal Disorders Treatment Market Value (US$ Mn), by Diabetic Retinopathy, 2018–2030
Figure 15: Global Retinal Disorders Treatment Market Value (US$ Mn), by Diabetic Macular Edema, 2018–2030
Figure 16: Global Retinal Disorders Treatment Market Value (US$ Mn), by Others (retinal vein occlusion, etc.), 2018–2030
Figure 17: Global Retinal Disorders Treatment Market Value Share Analysis, by Therapeutic Class, 2019 and 2030
Figure 18: Global Retinal Disorders Treatment Market Attractiveness Analysis, by Therapeutic Class, 2020–2030
Figure 19: Global Retinal Disorders Treatment Market Value (US$ Mn), by Anti-VEGF Agents, 2018–2030
Figure 20: Global Retinal Disorders Treatment Market Value (US$ Mn), by Others (anti-inflammatory drugs, etc.), 2018–2030
Figure 21: Global Retinal Disorders Treatment Market Value Share Analysis, by Dosage Form, 2019 and 2030
Figure 22: Global Retinal Disorders Treatment Market Attractiveness Analysis, by Dosage Form, 2020–2030
Figure 23: Global Retinal Disorders Treatment Market Value (US$ Mn), by Gels, 2018–2030
Figure 24: Global Retinal Disorders Treatment Market Value (US$ Mn), by Eye Solutions, 2018–2030
Figure 25: Global Retinal Disorders Treatment Market Value (US$ Mn), by Capsules & Tablets, 2018–2030
Figure 26: Global Retinal Disorders Treatment Market Value (US$ Mn), by Eye Drops, 2018–2030
Figure 27: Global Retinal Disorders Treatment Market Value (US$ Mn), by Ointments, 2018–2030
Figure 28: Global Retinal Disorders Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 29: Global Retinal Disorders Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 30: Global Retinal Disorders Treatment Market Value (US$ Mn), by Hospital Pharmacies, 2018–2030
Figure 31: Global Retinal Disorders Treatment Market Value (US$ Mn), by Retail Pharmacies, 2018–2030
Figure 32: Global Retinal Disorders Treatment Market Value (US$ Mn), by Online Sales, 2018–2030
Figure 33: Global Retinal Disorders Treatment Market Value Share Analysis, by Region, 2019 and 2030
Figure 34: Global Retinal Disorders Treatment Market Analysis, by Region
Figure 35: U.S. Retinal Disorders Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 36: U.S. Retinal Disorders Treatment Market Value Share Analysis, by Indication, 2019 and 2030
Figure 37: U.S. Retinal Disorders Treatment Market Attractiveness Analysis, by Indication, 2020–2030
Figure 38: U.S. Retinal Disorders Treatment Market Value Share Analysis, by Therapeutic Class, 2019 and 2030
Figure 39: U.S. Retinal Disorders Treatment Market Attractiveness Analysis, by Therapeutic Class, 2020–2030
Figure 40: U.S. Retinal Disorders Treatment Market Value Share Analysis, by Dosage Form, 2019 and 2030
Figure 41: U.S. Retinal Disorders Treatment Market Attractiveness Analysis, by Dosage Form, 2020–2030
Figure 42: U.S. Retinal Disorders Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 43: U.S. Retinal Disorders Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 44: Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 45: Europe Retinal Disorders Treatment Market Value Share Analysis, by Indication, 2019 and 2030
Figure 46: Europe Retinal Disorders Treatment Market Attractiveness Analysis, by Indication, 2020–2030
Figure 47: Europe Retinal Disorders Treatment Market Attractiveness Analysis, by Therapeutic Class, 2020–2030
Figure 48: Europe Retinal Disorders Treatment Market Value Share Analysis, by Dosage Form, 2019 and 2030
Figure 49: Europe Retinal Disorders Treatment Market Attractiveness Analysis, by Dosage Form, 2020–2030
Figure 50: Europe Retinal Disorders Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 51: Europe Retinal Disorders Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 52: Europe Retinal Disorders Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 53: Europe Retinal Disorders Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 54: China Retinal Disorders Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 55: China Retinal Disorders Treatment Market Value Share Analysis, by Indication, 2019 and 2030
Figure 56: China Retinal Disorders Treatment Market Attractiveness Analysis, by Indication, 2020–2030
Figure 57: China Retinal Disorders Treatment Market Value Share Analysis, by Therapeutic Class, 2019 and 2030
Figure 58: China Retinal Disorders Treatment Market Attractiveness Analysis, by Therapeutic Class, 2020–2030
Figure 59: China Retinal Disorders Treatment Market Value Share Analysis, by Dosage Form, 2019 and 2030
Figure 60: China Retinal Disorders Treatment Market Attractiveness Analysis, by Dosage Form, 2020–2030
Figure 61: China Retinal Disorders Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 62: China Retinal Disorders Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 63: Russia Retinal Disorders Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 64: Russia Retinal Disorders Treatment Market Value Share Analysis, by Indication, 2019 and 2030
Figure 65: Russia Retinal Disorders Treatment Market Attractiveness Analysis, by Indication, 2020–2030
Figure 66: Russia Retinal Disorders Treatment Market Value Share Analysis, by Therapeutic Class, 2019 and 2030
Figure 67: Russia Retinal Disorders Treatment Market Attractiveness Analysis, by Therapeutic Class, 2020–2030
Figure 68: Russia Retinal Disorders Treatment Market Value Share Analysis, by Dosage Form, 2019 and 2030
Figure 69: Russia Retinal Disorders Treatment Market Attractiveness Analysis, by Dosage Form, 2020–2030
Figure 70: Russia Retinal Disorders Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 71: Russia Retinal Disorders Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 72: Rest of the World (ROW) Retinal Disorders Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 73: Rest of the World (ROW) Retinal Disorders Treatment Market Value Share Analysis, by Indication, 2019 and 2030
Figure 74: Rest of the World (ROW) Retinal Disorders Treatment Market Attractiveness Analysis, by Indication, 2020–2030
Figure 75: Rest of the World (ROW) Retinal Disorders Treatment Market Value Share Analysis, by Therapeutic Class, 2019 and 2030
Figure 76: Rest of the World (ROW) Retinal Disorders Treatment Market Attractiveness Analysis, by Therapeutic Class, 2020–2030
Figure 77: Rest of the World (ROW) Retinal Disorders Treatment Market Value Share Analysis, by Dosage Form, 2019 and 2030
Figure 78: Rest of the World (ROW) Retinal Disorders Treatment Market Attractiveness Analysis, by Dosage Form, 2020–2030
Figure 79: Rest of the World (ROW) Retinal Disorders Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 80: Rest of the World (ROW) Retinal Disorders Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 81: Rest of the World (ROW) Retinal Disorders Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 82: Rest of the World (ROW) Retinal Disorders Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Retinal Disorders Treatment Market
